[1]
Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, Sinha AA, Payne AS, Daneshpazhooh M, Eming R, Jonkman MF, Mimouni D, Borradori L, Kim SC, Yamagami J, Lehman JS, Saleh MA, Culton DA, Czernik A, Zone JJ, Fivenson D, Ujiie H, Wozniak K, Akman-Karakaş A, Bernard P, Korman NJ, Caux F, Drenovska K, Prost-Squarcioni C, Vassileva S, Feldman RJ, Cardones AR, Bauer J, Ioannides D, Jedlickova H, Palisson F, Patsatsi A, Uzun S, Yayli S, Zillikens D, Amagai M, Hertl M, Schmidt E, Aoki V, Grando SA, Shimizu H, Baum S, Cianchini G, Feliciani C, Iranzo P, Mascaró JM Jr, Kowalewski C, Hall R, Groves R, Harman KE, Marinkovich MP, Maverakis E, Werth VP. Diagnosis and management of pemphigus: Recommendations of an international panel of experts. Journal of the American Academy of Dermatology. 2020 Mar:82(3):575-585.e1. doi: 10.1016/j.jaad.2018.02.021. Epub 2018 Feb 10
[PubMed PMID: 29438767]
[2]
Ioannides D, Hytiroglou P, Phelps RG, Bystryn JC. Regional variation in the expression of pemphigus foliaceus, pemphigus erythematosus, and pemphigus vulgaris antigens in human skin. The Journal of investigative dermatology. 1991 Feb:96(2):159-61
[PubMed PMID: 1991976]
[3]
Warren SJ, Arteaga LA, Rivitti EA, Aoki V, Hans-Filho G, Qaqish BF, Lin MS, Giudice GJ, Diaz LA. The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus. The Journal of investigative dermatology. 2003 Jan:120(1):104-8
[PubMed PMID: 12535205]
Level 2 (mid-level) evidence
[4]
Arteaga LA, Prisayanh PS, Warren SJ, Liu Z, Diaz LA, Lin MS, Cooperative Group on Fogo Selvagem Research. A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3. The Journal of investigative dermatology. 2002 May:118(5):806-11
[PubMed PMID: 11982757]
[5]
Pollmann R, Schmidt T, Eming R, Hertl M. Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches. Clinical reviews in allergy & immunology. 2018 Feb:54(1):1-25. doi: 10.1007/s12016-017-8662-z. Epub
[PubMed PMID: 29313220]
[6]
Santi CG, Sotto MN. Immunopathologic characterization of the tissue response in endemic pemphigus foliaceus (fogo selvagem). Journal of the American Academy of Dermatology. 2001 Mar:44(3):446-50
[PubMed PMID: 11209113]
[7]
Sokol E, Kramer D, Diercks GFH, Kuipers J, Jonkman MF, Pas HH, Giepmans BNG. Large-Scale Electron Microscopy Maps of Patient Skin and Mucosa Provide Insight into Pathogenesis of Blistering Diseases. The Journal of investigative dermatology. 2015 Jul:135(7):1763-1770. doi: 10.1038/jid.2015.109. Epub 2015 Mar 19
[PubMed PMID: 25789704]
[8]
Gomi H, Kawada A, Amagai M, Matsuo I. Pemphigus erythematosus: detection of anti-desmoglein-1 antibodies by ELISA. Dermatology (Basel, Switzerland). 1999:199(2):188-9
[PubMed PMID: 10559598]
[9]
Shirakata Y, Amagai M, Hanakawa Y, Nishikawa T, Hashimoto K. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. The Journal of investigative dermatology. 1998 Jan:110(1):76-8
[PubMed PMID: 9424092]
[10]
Jordan TJM, Affolter VK, Outerbridge CA, Goodale EC, White SD. Clinicopathological findings and clinical outcomes in 49 cases of feline pemphigus foliaceus examined in Northern California, USA (1987-2017). Veterinary dermatology. 2019 Jun:30(3):209-e65. doi: 10.1111/vde.12731. Epub 2019 Feb 18
[PubMed PMID: 30779233]
Level 2 (mid-level) evidence
[11]
Sawamura S, Kajihara I, Makino K, Makino T, Fukushima S, Jinnin M, Oyama B, Hashimoto T, Ihn H. Systemic lupus erythematosus associated with myasthenia gravis, pemphigus foliaceus and chronic thyroiditis after thymectomy. The Australasian journal of dermatology. 2017 Aug:58(3):e120-e122. doi: 10.1111/ajd.12510. Epub 2016 Jun 7
[PubMed PMID: 27270472]
[12]
Jiao D, Bystryn JC. Sensitivity of indirect immunofluorescence, substrate specificity, and immunoblotting in the diagnosis of pemphigus. Journal of the American Academy of Dermatology. 1997 Aug:37(2 Pt 1):211-6
[PubMed PMID: 9270506]
[13]
Sar-Pomian M, Kurzeja M, Rudnicka L, Olszewska M. The value of trichoscopy in the differential diagnosis of scalp lesions in pemphigus vulgaris and pemphigus foliaceus. Anais brasileiros de dermatologia. 2014 Nov-Dec:89(6):1007-12
[PubMed PMID: 25387515]
[14]
Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus., Sami N,Qureshi A,Ahmed AR,, European journal of dermatology : EJD, 2002 Mar-Apr
[PubMed PMID: 11872417]
[15]
Hymes SR, Jordon RE. Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy. Archives of dermatology. 1992 Nov:128(11):1462-4
[PubMed PMID: 1444499]